- Residency - UT Health Science Center McGovern Medical School (1995-1998), Pathology
- Internship - Baylor College of Medicine (1994-1995), Internal Medicine
- Fellowship - Johns Hopkins Hospital (1999-2001), Pathology
- Medical School - UT Health Science Center at San Antonio School of Medicine (1989-1993)
- Internship - Baylor College of Medicine (1993-1994), Pathology
- Fellowship - UT Southwestern Medical Center (1998-1999), Surgical Pathology
Dwight Oliver, M.D.
- Pathology
- Surgical Pathology
- Molecular Diagnostics
Biography
Dwight Oliver, M.D., is a Professor in the Department of Pathology at UT Southwestern Medical Center. He specializes in translational research in oncology, and design, development, and validation of clinical molecular diagnostic assays for oncology and infectious diseases.
Dr. Oliver earned his medical degree at The University of Texas Health Science Center at San Antonio School of Medicine and completed a residency in pathology at the UTHealth Houston McGovern Medical School, where he served as Chief Resident. He gained advanced training through a fellowship in surgical pathology at UT Southwestern and a fellowship in molecular diagnostics and molecular pathology at The Johns Hopkins Hospital in Baltimore, Maryland. He also holds a Doctor of Optometry degree from the Pennsylvania College of Optometry in Philadelphia.
Certified by the American Board of Pathology in anatomic and clinical pathology and molecular genetic pathology, he joined the UT Southwestern faculty in 2008.
Dr. Oliver serves as Medical Director of UT Southwestern’s Molecular Diagnostics Laboratory and Director of the Molecular Genetic Pathology Fellowship Program. He is a member of the Association for Molecular Pathology, the American Association for Cancer Research, and the College of American Pathologists.
He has delivered numerous presentations, contributed to the books Basic Concepts of Molecular Pathology and Molecular Pathology of Lung Diseases, and published many peer-reviewed academic articles related to his areas of expertise. He is a section editor for Journal of Molecular Pathology and Archives of Pathology & Laboratory Medicine, as well as a reviewer for the College of American Pathologists National Meeting Abstract Review Committee.
Education & Training
Professional Associations & Affiliations
- American Association for Cancer Research
- Association for Molecular Pathology
- College of American Pathologists
Honors & Awards
- Excellence in Clinical Research, Pathology Young Investigator Award 2001, Johns Hopkins
- Helen Chu Wagner Award 1998, UTHealth Houston McGovern Medical School
- A.O. Severance Pathology Scholarship 1993, University of Texas Health Science Center at San Antonio
Books & Publications
-
Books
-
Polymerase Chain Reaction and Reverse Transcription-Polymerase Chain Reaction in Basic Concepts of Molecular Pathology
Oliver D (2009), New York, Springer -
Polymerase Chain Reaction and Reverse Transcription-Polymerase Chain Reaction in Molecular Pathology of Lung Diseases
Oliver D (2008), New York, Springer
-
Polymerase Chain Reaction and Reverse Transcription-Polymerase Chain Reaction in Basic Concepts of Molecular Pathology
-
Publications
-
Serum D-2-hydroxyglutarate and the ratio of D-2HG/L-2HG predict IDH mutation in acute myeloid leukemia.
Zhang C, Chu A, Boriack R, Collins R, Xu J, Oliver D, Zheng R, Rakheja D, Chen W, EJHaem 2023 Aug 4 3 723-727 -
Acute graft-versus-host disease after double lung transplant confirmed by short tandem repeat analysis to identify donor chimerism in the skin.
Valencia J, Kaza V, Kim JK, Oliver D, Vandergriff T, Wysocki C, Dominguez AR, JAAD case reports 2023 Jun 36 24-27 -
Stepped Behavioral and Biological Screening for Oral Oncogenic HPV DNA in Middle-aged and Elderly Adults: A Feasibility Study.
Day AT, Sample RA, Salley JR, Oliver D, Dahlstrom KR, Sturgis EM, Tiro JA, Cancer prevention research (Philadelphia, Pa.) 2023 Mar 16 3 127-132 -
Case Report of Fibro-Adipose Vascular Anomaly (FAVA) with Activating Somatic PIK3CA Mutation.
Driskill JH, Hwang H, Callan AK, Oliver D, Case reports in genetics 2022 2022 9016497 -
Digital Droplet PCR for SARS-CoV-2 Resolves Borderline Cases.
Xu J, Kirtek T, Xu Y, Zheng H, Yao H, Ostman E, Oliver D, Malter JS, Gagan JR, SoRelle JA, American journal of clinical pathology 2021 05 155 6 815-822 -
Lenalidomide-Associated Secondary B-Lymphoblastic Leukemia/Lymphoma-A Unique Entity.
Germans SK, Kulak O, Koduru P, Oliver D, Gagan J, Patel P, Anderson LD, Fuda FS, Chen W, Jaso JM, American journal of clinical pathology 2020 Sep -
Diagnostic Performance of a Rapid Point of Care Test for SARS-CoV-2 in an Urban ED Setting.
McDonald S, Courtney DM, Clark AE, Muthukumar A, Lee F, Balani J, Mahimainathan L, Bararia A, Oliver D, Sarode R, Diercks D, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 2020 Jun -
Does Tumor FDG-PET-Avidity Represent Enhanced Glycolytic Metabolism in Non-Small Cell Lung Cancer?
Kernstine KH, Faubert B, Do QN, Rogers TJ, Hensley CT, Cai L, Torrealba J, Oliver D, Waschmann JW, Lenkinski RE, Malloy CR, Deberardinis RJ, The Annals of thoracic surgery 2019 Dec -
Genome-Wide Analysis of Glioblastoma Patients with Unexpectedly Long Survival.
Richardson TE, Patel S, Serrano J, Sathe AA, Daoud EV, Oliver D, Maher EA, Madrigales A, Mickey BE, Taxter T, Jour G, White CL, Raisanen JM, Xing C, Snuderl M, Hatanpaa KJ, Journal of neuropathology and experimental neurology 2019 Apr -
Lactate Metabolism in Human Lung Tumors.
Faubert B, Li KY, Cai L, Hensley CT, Kim J, Zacharias LG, Yang C, Do QN, Doucette S, Burguete D, Li H, Huet G, Yuan Q, Wigal T, Butt Y, Ni M, Torrealba J, Oliver D, Lenkinski RE, Malloy CR, Wachsmann JW, Young JD, Kernstine K, DeBerardinis RJ Cell 2017 Oct 171 2 358-371.e9 -
Rapid progression to glioblastoma in a subset of IDH-mutated astrocytomas: a genome-wide analysis.
Richardson TE, Snuderl M, Serrano J, Karajannis MA, Heguy A, Oliver D, Raisanen JM, Maher EA, Pan E, Barnett S, Cai C, Habib AA, Bachoo RM, Hatanpaa KJ Journal of neuro-oncology 2017 Apr -
Histologic transformation of EGFR mutant lung adenocarcinoma without exposure to EGFR inhibition.
Le T, Sailors J, Oliver DH, Mayer M, Hoskin S, Gerber DE Lung cancer (Amsterdam, Netherlands) 2017 Mar 105 14-16 -
Non-malignant respiratory epithelial cells preferentially proliferate from resected non-small cell lung cancer specimens cultured under conditionally reprogrammed conditions.
Gao B, Huang C, Kernstine K, Pelekanou V, Kluger Y, Jiang T, Peters-Hall JR, Coquelin M, Girard L, Zhang W, Huffman K, Oliver D, Kinose F, Haura E, Teer JK, Rix U, Le AT, Aisner DL, Varella-Garcia M, Doebele RC, Covington KR, Hampton OA, Doddapaneni HV, Jayaseelan JC, Hu J, Wheeler DA, Shay JW, Rimm DL, Gazdar A, Minna JD Oncotarget 2016 Dec -
Prospective Longitudinal Analysis of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy Identifies Broad Clinical Utility for the Management of Patients With IDH-Mutant Glioma.
Choi C, Raisanen JM, Ganji SK, Zhang S, McNeil SS, An Z, Madan A, Hatanpaa KJ, Vemireddy V, Sheppard CA, Oliver D, Hulsey KM, Tiwari V, Mashimo T, Battiste J, Barnett S, Madden CJ, Patel TR, Pan E, Malloy CR, Mickey BE, Bachoo RM, Maher EA Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Nov 34 33 4030-4039 -
Metabolic Heterogeneity in Human Lung Tumors.
Hensley CT, Faubert B, Yuan Q, Lev-Cohain N, Jin E, Kim J, Jiang L, Ko B, Skelton R, Loudat L, Wodzak M, Klimko C, McMillan E, Butt Y, Ni M, Oliver D, Torrealba J, Malloy CR, Kernstine K, Lenkinski RE, DeBerardinis RJ Cell 2016 Feb 164 4 681-94 -
Potential pitfalls of mass spectrometry to uncover mutations in childhood soft tissue sarcoma: A report from the Children's Oncology Group.
Xu L, Wilson RA, Laetsch TW, Oliver D, Spunt SL, Hawkins DS, Skapek SX Scientific reports 2016 6 33429 -
Histologic Transformation from Adenocarcinoma to Squamous Cell Carcinoma as a Mechanism of Resistance to EGFR Inhibition.
Levin PA, Mayer M, Hoskin S, Sailors J, Oliver DH, Gerber DE Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2015 Sep 10 9 e86-8 -
The importance of plasma D-2HG measurement in screening for IDH mutations in acute myeloid leukaemia.
McGehee E, Rakheja D, Oliver D, Chen W, Boriack R, Collins RH British journal of haematology 2015 Jul -
Defining early mycosis fungoides: validation of a diagnostic algorithm proposed by the International Society for Cutaneous Lymphoma.
Vandergriff T, Nezafati KA, Susa J, Karai L, Sanguinetti A, Hynan LS, Ambruzs JM, Oliver DH, Pandya AG Journal of cutaneous pathology 2015 Feb -
Hereditary Lung Cancer Syndrome Targets Never Smokers with Germline EGFR Gene T790M Mutations.
Gazdar A, Robinson L, Oliver D, Xing C, Travis WD, Soh J, Toyooka S, Watumull L, Xie Y, Kernstine K, Schiller JH Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2014 Apr 9 4 456-63 -
High expression of the stem cell marker nestin is an adverse prognostic factor in WHO grade II-III astrocytomas and oligoastrocytomas.
Hatanpaa KJ, Hu T, Vemireddy V, Foong C, Raisanen JM, Oliver D, Hiemenz MC, Burns DK, White CL, Whitworth LA, Mickey B, Stegner M, Habib AA, Fink K, Maher EA, Bachoo RM Journal of neuro-oncology 2014 Mar 117 1 183-9 -
Petrous apex vascular malformation.
Purcell P, Isaacson B, Oliver DH, Roland PS Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2012 Oct 33 8 e67-8 -
Distinct immunophenotype of early T-cell progenitors in T lymphoblastic leukemia/lymphoma may predict FMS-like tyrosine kinase 3 mutations.
Zaremba CM, Oliver D, Cavalier M, Fuda F, Karandikar NJ, Chen W Annals of diagnostic pathology 2012 Jan 16 1 16-20 -
Infantile mixed phenotype acute leukemia (bilineal and biphenotypic) with t(10;11)(p12;q23);MLL-MLLT10.
Lou Z, Zhang CC, Tirado CA, Slone T, Zheng J, Zaremba CM, Oliver D, Chen W Leukemia research 2010 Aug 34 8 1107-9 -
Intestinal edema: effect of enteral feeding on motility and gene expression.
Moore-Olufemi SD, Padalecki J, Olufemi SE, Xue H, Oliver DH, Radhakrishnan RS, Allen SJ, Moore FA, Stewart R, Laine GA, Cox CS The Journal of surgical research 2009 Aug 155 2 283-92 -
Chondroblastoma of the temporomandibular joint: report of a case and literature review.
Bui P, Ivan D, Oliver D, Busaidy KF, Wilson J Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 2009 Feb 67 2 405-9 -
Fever-range whole-body thermal therapy combined with cisplatin, gemcitabine, and daily interferon-alpha: a description of a phase I-II protocol.
Bull JM, Scott GL, Strebel FR, Nagle VL, Oliver D, Redwine M, Rowe RW, Ahn CW, Koch SM International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2008 Dec 24 8 649-62 -
Fine needle aspiration biopsy and immunostaining findings in an aggressive inflammatory myofibroblastic tumor of the lung: a case report.
Hannah CD, Oliver DH, Liu J Acta cytologica 2007 Mar-Apr 51 2 239-43 -
Resuscitation-induced gut edema and intestinal dysfunction.
Moore-Olufemi SD, Xue H, Attuwaybi BO, Fischer U, Harari Y, Oliver DH, Weisbrodt N, Allen SJ, Moore FA, Stewart R, Laine GA, Cox CS The Journal of trauma 2005 Feb 58 2 264-70 -
Management of anomalies of the third and fourth branchial pouches.
Pereira KD, Losh GG, Oliver D, Poole MD International journal of pediatric otorhinolaryngology 2004 Jan 68 1 43-50 -
8-Hydroxyguanosine repair is defective in some microsatellite stable colorectal cancer cells.
Parker AR, O'Meally RN, Oliver DH, Hua L, Nelson WG, DeWeese TL, Eshleman JR Cancer research 2002 Dec 62 24 7230-3 -
Use of single nucleotide polymorphisms (SNP) and real-time polymerase chain reaction for bone marrow engraftment analysis.
Oliver DH, Thompson RE, Griffin CA, Eshleman JR The Journal of molecular diagnostics : JMD 2000 Nov 2 4 202-8
-
Serum D-2-hydroxyglutarate and the ratio of D-2HG/L-2HG predict IDH mutation in acute myeloid leukemia.
Research
- Translational research in oncology
- Design, development, and validation of clinical molecular diagnostic assays for oncology and infectious diseases
Clinical Focus
- Surgical Pathology
- Molecular Diagnostics
- Molecular Pathology